Zevra Therapeutics announced that it has become a Corporate Council member of the National Organization for Rare Disorders and reiterated its commitment to the rare disease community by celebrating Rare Disease Day 2023.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on KMPH:
- Zevra Therapeutics Begins Trading as ZVRA
- Zevra Therapeutics, a Rare Disease Therapeutics Company, Files Preliminary Proxy
- Zevra Therapeutics to Report Fourth Quarter and Full-Year 2022 Results
- Zevra announces arimoclomol featured in two poster presentations
- Zevra Therapeutics Announces Arimoclomol Research Featured in Two Poster Presentations at the 19th Annual WORLDSymposium™ 2023
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue